Novo Nordisk Other Share Holders Equity 2010-2024 | NVO

Novo Nordisk other share holders equity for the quarter ending December 31, 2024 was $-0.204B, a 210.04% decline year-over-year.

  • Novo Nordisk other share holders equity for 2024 was $-0.204B, a 210.04% decline from 2023.
  • Novo Nordisk other share holders equity for 2023 was $0.185B, a 46.57% decline from 2022.
  • Novo Nordisk other share holders equity for 2022 was $0.347B, a 227.17% decline from 2021.

Novo Nordisk Other Share Holders Equity 2010-2024 | NVO

  • Novo Nordisk other share holders equity for 2024 was $-0.204B, a 210.04% decline from 2023.
  • Novo Nordisk other share holders equity for 2023 was $0.185B, a 46.57% decline from 2022.
  • Novo Nordisk other share holders equity for 2022 was $0.347B, a 227.17% decline from 2021.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$827.9B
Johnson & Johnson (JNJ)$384.4B
AbbVie (ABBV)$354.6B
Roche Holding AG (RHHBY)$262.5B
Merck (MRK)$221.8B
Novartis AG (NVS)$219.3B
Pfizer (PFE)$146.8B
Sanofi (SNY)$137.4B
Bayer (BAYRY)$22.6B
Innoviva (INVA)$1.1B